Earlier this year, the World Health Organization (WHO) published a report on the “Ten Threats to Global Health in 2019”, which highlighted the main threats to human health across the globe . The comprehensive list comprised an array of well-known threats including non-communicable diseases such as cancer, type-2-diabetes, cardiovascular disease and stroke, as well as emerging threats such as antimicrobial resistance.
It may, therefore, come as no surprise that Pittcon 2019 will feature biomedical researchers from around the world who are working diligently to address these important health issues through the development of new techniques and technologies.
The Pittcon 2019 Technical Program will be held in Philadelphia from March 17th-21st 2019 and will showcase a range of biomedical methodologies which can provide improved diagnostics, better treatments, faster discovery and ultimately improved medical outcomes.
Spectroscopic approaches to global health threats
Spectroscopy is fast becoming one of the greatest advances in biomedicine. Raman spectroscopy is just one of the many spectroscopic techniques that will be featured at Pittcon 2019. Raman is a low-energy, non-destructive and non-invasive technique that can be used to image even delicate tissues in situ. The only limitation of Raman is the signal to noise ratio, as low energy signals can be swamped and lost in the noise. This has been addressed through the development of combinatorial techniques such as Stimulated Raman Scattering (SRS), which has recently been used to image brain tissue in Alzheimer’s disease.
To demonstrate how Raman spectroscopy can be coupled with photoacoustic imaging. Professor Dan Fu of the University of Washington will present his research at Pittcon 2019 in a talk entitled “Label-Free Chemical Imaging of Brain Structure and Function at Subcellular Resolution”. In this presentation he will show that Stokes Raman Scattering (SRS) is able to detect synaptic acetylcholine, plaque structure, and even complex cell organization without any labelling in Alzheimer’s research.
Raman spectroscopy has slipped into biomedical science proving its utility in medical diagnostics for diseases as diverse as cancer, cardiovascular disease and bacterial infections. Raman is proving its value in both the diagnostic laboratory and the clinical environment.
Professor Jurgen Popp is a great advocate for Raman spectroscopy and is an expert in his field. He received the 2016 Pittsburgh Spectroscopy Award at Pittcon 2016 and will give a presentation entitled “Clinical Cell and Tissue Diagnostics by Multimodal Molecular Spectroscopy”. This work will examine advances in spectroscopic methods, especially Raman spectroscopy and combinatorial spectroscopic or optical procedures to analyze cells and tissue in pathological samples. Popp will also demonstrate the potential of Raman spectroscopy as a point-of-care method for a fast identification of pathogens.
Transmission Raman spectroscopy (TRS) is a further example of a developing biomedical Raman technique. The method works by illuminating the sample on one-side and collecting the transmitted light on the other side. This technique has become a non-invasive technique for the analysis of breast calcification detected from mammograms.
Nick Stone, Professor of Biomedical Imaging and Biosensing at the University of Exeter, will present his research paper at Pittcon 2019 entitled “Biomedical Spectroscopic Tools for Rapid Analysis of Disease Specific Changes Using Novel Raman and IR Techniques”. This will show how Raman and IR spectroscopy is being used for the rapid and accurate analysis of tissues in pathology, high-speed spectral histopathology.
Microfluidic lab-on-a-chip technology, combined with spectroscopy has the potential to become a new biomedical analytical phenomenon. Microfluidic systems are more cost effective than traditional methods, require minimal training, provide faster results and improved accuracy.
Dr Ester Segal of Technion is an expert in microfluidics and will present a talk entitled “On-Chip Rapid Diagnostic Susceptibility Testing of Bacteria and Fungi from Clinical Samples” at Pittcon 2019. This will showcase the testing of microorganisms for antibiotic resistance using a functionalized photonic 2D silicon microarray as a platform.
Immunohistochemistry and radiolabelling have revolutionized the visualization and detection of compounds in pathological tissue samples. But now, high-throughput, high-speed MALDI (matrix assisted laser desorbed ionization) mass spectrometry imaging has arrived. MALDI Imaging mass spectrometry (MALDI-IMS) can be used to analyse complex mixtures ranging from small molecules to complex peptides in a proteome. This method also has the advantage that it does not harm the sample.
A recognized authority in mass spectrometry imaging, Professor Pierre Chaurand of the University of Montreal, will present his research in a presentation entitled “Image MS of Tissue Biopsies to Assess Diagnosis, Prognosis and Response to Therapies” at Pittcon 2019.
Researchers are continually searching for new biomarkers for health threats, including cancer, neurological diseases, and cardiovascular diseases. If molecular signatures of disease can be identified early then rapid and targeted treatment can improve patient survival providing an economic advantage.
A potential method for discovering new biomarkers in lung disease is exhaled breath condensate (EBC). EBC is a body fluid matrix in which biomarkers may be identified and is considered by many to be equivalent to blood, sweat, tears, urine and saliva.
A presentation entitled “Human Exhaled Breath Aerosol Collection in the Clinical Setting - Techniques, Concerns, and Considerations” will be provided by Professor Michael D Davis of the Children's Hospital of Richmond, Virginia Commonwealth University (VCU). The talk will provide an overview of collection techniques and analysis for EBC.
An area where biomarkers are needed urgently is Alzheimer’s disease (AD). AD is a major public health issue; the condition is the 6th leading cause of death in the US and around 5.7 million American citizens live with the disease at any one time. Currently, a definitive diagnosis of AD requires post-mortem slides of neural material. It is hoped that a series of new biomarkers will provide a definitive diagnosis for living patients and help scientists to understand the progression of the disease at a molecular level. Two approaches that are currently being utilized for the discovery of new biomarkers are proteomics and lipidomics studies on blood and post-mortem tissues.
The potential of these techniques will be outlined by Dr Rena Robinson of Vanderbilt University, who will present her paper at Pittcon 2019, entitled “Comprehensive Proteomics and Lipidomics Strategies to Advance Alzheimer's Disease Research”. This will define a high-throughput quantitative proteomics method to provide hundreds of proteins distinct to specific disease genotypes.
Biomarkers and metabolomics
Metabolites are the intermediates and products of metabolism. Cells constantly carry out discrete physiological processes and these can be affected by human disease. To determine the structure and regulation of metabolic pathways is essential especially in brain tissue for researching AD.
Monitoring brain chemistry metabolites is, however, a challenging area. In this case, biosensors have been used to understand brain energy metabolism and neurotransmission. The sensors provide timed temporal resolution and enzymatic assaying of any redox or non-redox molecule. This can be of great help in the real-time monitoring of brain chemistry during the course of traumatic brain injury (TBI). However, despite the miniature size of the of the biosensors, implantation is often considered dangerous and comes with major health risks.
At Pittcon 2019, Dr Stéphane Marinesco of INSERM will give a presentation entitled “Ultra-small Microelectrode Biosensors based on Platinized Carbon Fibers for Brain Injury Monitoring”. This research will demonstrate how ultra-small microelectrodes are implanted in the brain to provide accurate estimates of oxygen, glucose and lactate and other essential compounds. The idea is that this technology could monitor changes occurring in traumatic brain injury and provide improved diagnosis.
Biomedical sciences at Pittcon 2019
The technology and research methodology mentioned in this summary will be examined in more detail in the Pittcon 2019 oral and poster presentations, symposia and short technical courses. The Pittcon 2019 guide can provide details of times, venues and biographies of the presenters as well as an abstract of each talk.
The Pittcon 2019 EXPO will feature all of the leading manufacturers and developers of biomedical research equipment including: Thermo Fisher, Waters Corporation, Bruker, Agilent Technologies, Horiba and Specac. These companies will be glad to meet with you to demonstrate their products and discuss your requirements.
- Ten threats to global health in 2019, https://www.who.int/emergencies/ten-threats-to-global-health-in-2019 Accessed 4th March 2019
- M Ji, S Lewis, S Camelo-Piragua, SH Ramkissoon, M Snuderl, S Venneti, Detection of human brain tumor infiltration with quantitative stimulated Raman scattering microscopy, Science translational medicine 7 (309), 2010, 309ra163-309ra163
- Nadine Vogler, Sandro Heuke, Thomas W. Bocklitz, Michael Schmitt, Jürgen Popp, Multimodal Imaging Spectroscopy of Tissue, Annual Review of Analytical Chemistry 2015 8:1, 359-387
- Ghita, A, Matousek, P. and Stone, N. (2018), High sensitivity non‐invasive detection of calcifications deep inside biological tissue using Transmission Raman Spectroscopy. J. Biophotonics, 11: e201600260.
- Leonard, Heidi & Colodner, Raul & Halachmi, Sarel & Segal, Ester. (2018). Recent Advances in the Race to Design a Rapid Diagnostic Test for Antimicrobial Resistance. ACS Sensors. 3. 10.1021/acssensors.8b00900
- P Chaurand, Imaging mass spectrometry of thin tissue sections: a decade of collective efforts, 2012, Journal of proteomics 75 (16), 4883-4892
- Albert B. Arul and Renã A. S. Robinson, Sample Multiplexing Strategies in Quantitative Proteomics, Analytical Chemistry, 2019, 91 (1), 178-189, DOI: 10.1021/acs.analchem.8b05626
- Tholance Y, Barcelos GK, Dailler F, Renaud B, Marinesco S, Perret-Liaudet A. Biochemical neuromonitoring of poor-grade aneurysmal subarachnoid hemorrhage: comparative analysis of metabolic events detected by cerebral microdialysis and by retrograde jugular vein catheterization. Neurological Research, 2015, 37: 578-87. PMID 25668478 DOI: 10.1179/1743132815Y.0000000012
Pittcon® is a registered trademark of The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, a Pennsylvania non-profit organization. Co-sponsored by the Spectroscopy Society of Pittsburgh and the Society for Analytical Chemists of Pittsburgh, Pittcon is the premier annual conference and exposition on laboratory science.
Proceeds from Pittcon fund science education and outreach at all levels, kindergarten through adult. Pittcon donates more than a million dollars a year to provide financial and administrative support for various science outreach activities including science equipment grants, research grants, scholarships and internships for students, awards to teachers and professors, and grants to public science centers, libraries and museums.
Visit pittcon.org for more information.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.